from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2106/-

LFCtreatmentdescriptionclass of inhibitor

-0.503

Amikacinug/mL Amikacintranslation

0.641

Cap5-10ug/mL Capreomycintranslation

0.483

Rox10-50 ug/mL Roxithromycintranslation

0.231

SM2-5 ug/mL Streptomycintranslation

0.425

Tet5-10 ug/mL Tetracyclinetranslation

-0.249

Rif0.2-5ug/mL Rifampicintranscription

-0.336

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.126

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.410

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.148

CPZ10-50 ug/mL Chlorpromazinerespiration

0.054

Clofazimine10-13 ug/mL Clofaziminerespiration

0.707

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.413

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.291

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.800

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.746

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.233

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.297

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.143

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.861

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.002

KCN5-20 ug/mL Potassium cyaniderespiration

-0.771

NaN30.2-2 mM Sodium aziderespiration

0.902

Nigericin50 uM Nigericinrespiration

0.024

TRC10-150 ug/mL Triclosanrespiration

-0.907

TRZ10-25 ug/mL Thioridazinerespiration

2.312

Valinomycin0.5-10 uM Valinomycinrespiration

1.590

ZnSO42 mM ZnSO4respiration

-1.556

menadione6-10 ug/mL Menadionerespiration

-0.319

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.301

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.655

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.562

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.447

NRP_1Non-replicating persistence stage 1dosRassociated

-0.689

Amp0.2mg/mL AmpicillincellWall

-0.106

Cephalexin20-100 ug/mL CephalexincellWall

0.039

Cerulenin0.32-5 ug/mL CerulenincellWall

0.051

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.088

EMB10-20 ug/mL EthambutolcellWall

-0.175

Eta12-40 ug/mL EthionamidecellWall

-0.524

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.368

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.801

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.709

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.740

BZA0.12 mg/mL BenzamidearomaticAmides

-0.698

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.749

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.337

H2O24 mM hydrogen peroxideDNAdamaging

-0.222

Levo10 ug/mL LevofloxacinDNAdamaging

-0.051

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.198

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.091

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.096

UVUV-irradiationDNAdamaging

-0.938

ARP41-4 ug/mL Antitubercular compound ARP4?

0.499

Antimycin12.5-50 ug/mL Antimycin A?

0.301

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.044

PA_110-50 ug/mL Antitubercular compound PA-1?

0.888

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.052

PA8240.2-2 ug/mL PA-824?

-0.679

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.261

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.237

Verapamil50 uM Verapamil?

0.336

mercaptoethanol2 mM 2-Mercaptoethanol?

0.516

methoxatin10-20 ug/mL Methoxatin?